Reconsidering medication appropriateness for patients late in life.
about
Prioritizing and stopping prescription medicines.Routine deprescribing of chronic medications to combat polypharmacyThe effect of statins on average survival in randomised trials, an analysis of end point postponementSystematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adultsPrognostic indices for older adults: a systematic reviewThe impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysisLipid-modifying therapy in the elderlyThe views of healthcare professionals, drug developers and regulators on information about older people needed for rational drug prescriptionWhat are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi processA Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.High prevalence of central nervous system medications in community-dwelling older adults with dementia over a three-year period.Atherosclerotic Cardiovascular Disease Risk and Evidence-based Management of Cholesterol.Incorporating lag time to benefit into prevention decisions for older adultsImpact of prescribed medications on patient safety in older people.Perspectives of carers on medication management in dementia: lessons from collaboratively developing a research proposalDaily medication use in nursing home residents with advanced dementia.Disparities in combination drug therapy use in older adults with coronary heart disease: a cross-sectional time-series in a nationally representative US sample.Patterns of multimorbidity in elderly veteransA cross-sectional analysis of the prevalence of undertreatment of nonpain symptoms and factors associated with undertreatment in older nursing home hospice/palliative care patients.Utilization of potentially inappropriate medications in elderly patients in a tertiary care teaching hospital in India.Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study.Managing medications in clinically complex elders: "There's got to be a happy medium".Cholinesterase inhibitor and N-methyl-D-aspartic acid receptor antagonist use in older adults with end-stage dementia: a survey of hospice medical directors.Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process.Withdrawing medication: managing medical comorbidities near the end of lifeThe payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines.From Bedside to Bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older AdultsPreventive medication use among persons with limited life expectancy.Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents.Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity"Knowing is better": preferences of diverse older adults for discussing prognosisA Delphi process to address medication appropriateness for older persons with multiple chronic conditions.Prescribing for Australians living with dementia: study protocol using the Delphi technique.Adverse drug reactions in special populations - the elderly.Quinine induced simvastatin toxicity through cytochrome inhibition - a case report.Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.A framework for tailoring clinical guidelines to comorbidity at the point of careUse of medications of questionable benefit in advanced dementia.
P2860
Q24541841-CCF04C06-8FCF-46EF-82DC-59D827E82EDAQ26775802-6D47125A-3B02-40FF-9DEC-E8EACCD31415Q26786733-1AF10898-926C-4F7C-9727-9078F9E48C4CQ26796403-7E221350-1935-40FB-ACEA-303611D6AF05Q26865698-806436D7-0834-49F2-B2B1-90A3C9FE5366Q28083527-81827BC6-C9EB-44A0-9A9D-41FAF839D910Q28088296-9CA7D881-AB41-4A58-A109-44DCAA8687F6Q28535398-2EC5450E-81BF-4F7A-BCA3-902497EB5CDEQ28545785-74380473-1A2D-454D-9275-BD46982F49E2Q30276856-8926A4AE-B405-4B5F-A494-AE1D7B2ED743Q33155526-7330ACCB-402A-4E5F-9479-AD3D71CDFAC0Q33724722-1BB9699D-DF47-45AC-B4A9-1717C3EC6B27Q33725622-EAD50385-60DE-46CD-B73B-BBAD298BF319Q33949432-983EADD7-D7C7-446B-A8A0-D9DF7303A7CBQ33958569-B17BFD4F-DFE6-468F-A4D9-C88A67EE0140Q34020509-F7F48EE8-3D55-4DB9-80B0-DE09109F5EADQ34043561-128A6C96-9F21-47E6-999C-BCB51E1F7E37Q34049889-E56508C6-CF57-4064-BF12-A7F00575D19AQ34087682-A7549FEE-9092-4AE8-A6A6-C1A2FE536925Q34221335-C22E978B-5960-4367-9CBA-596E5DB9A5D7Q34304152-94819C45-6DF6-4B92-8CEC-BBC396A71CB0Q34311242-5E0A4B01-0402-414F-871C-1237D73123CBQ34334170-6C461F03-6955-4651-9D7B-84129E69E40CQ34418562-407E398D-6FB5-4615-8B58-749001B97929Q34522113-A998F3DB-FD46-48F7-8FFB-B64842DC8949Q34554391-3233E81F-16D1-42E6-9BC9-E0934172E63DQ34667905-D623CCED-8D03-4A7A-BDB2-F436587965D5Q34802701-D3536189-A9AD-4AA2-8368-592186720258Q35014055-5F75B11B-FC7E-44A9-96F7-A724553776DFQ35055271-9C41217D-BEBA-448D-BD44-C2501DC7BC34Q35149401-88756A64-C025-4971-AEE7-A1F014255E43Q35695252-3AC07B31-1E95-4933-9633-5D9FC5D4248BQ35888174-ED4ED5A7-BF3A-4A6C-AE31-A3934D34144DQ35958454-758D6D03-B7F4-4A98-8563-E028319734CFQ35959891-30304155-EB54-466D-ABFB-3B6540C98F42Q36125513-E9F333F7-D63D-4560-BF6B-D69CDE7BD14CQ36156619-B6F52B9C-C234-4A4F-91DE-5959A85056D4Q36200626-A00D6C9A-FD2C-4CCE-A835-7B8852CE40DBQ36285981-8626FB69-3985-49B1-AB2E-DA775042D024Q36398853-3E2AC355-8E30-4795-A75C-4C9963336AFF
P2860
Reconsidering medication appropriateness for patients late in life.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Reconsidering medication appropriateness for patients late in life.
@ast
Reconsidering medication appropriateness for patients late in life.
@en
type
label
Reconsidering medication appropriateness for patients late in life.
@ast
Reconsidering medication appropriateness for patients late in life.
@en
prefLabel
Reconsidering medication appropriateness for patients late in life.
@ast
Reconsidering medication appropriateness for patients late in life.
@en
P2093
P1476
Reconsidering medication appropriateness for patients late in life.
@en
P2093
Déon Cox Hayley
G Caleb Alexander
Greg A Sachs
Holly M Holmes
P304
P356
10.1001/ARCHINTE.166.6.605
P407
P577
2006-03-01T00:00:00Z